Results 191 to 200 of about 19,735 (216)
Some of the next articles are maybe not open access.

Shiga Toxin Associated Hemolytic Uremic Syndrome

Hematology/Oncology Clinics of North America, 2015
Shiga toxin associated hemolytic uremic syndrome (Stx HUS), a thrombotic microangiopathy, is the most common cause of pediatric acute kidney injury but has no direct treatment. A better understanding of disease pathogenesis may help identify new therapeutic targets. For this reason, the role of complement is being actively studied while eculizumab, the
openaire   +2 more sources

Escherichia coli Shiga toxin.

Journal of natural toxins, 2001
The Stx family contains two types called Stx1 (verotoxin 1: VT1 or Shiga-like toxin: SLT1) and Stx2 (VT2, SLT2); both toxins are encoded by bacteriophages. Stx1 is identical to Shiga toxin produced by Shigella dysenteriae type I. Stx2 is heterogeneous and immunologically different from Stx1. Although many variations are found in Stx family, all Stx has
H, Nakao, T, Takeda
openaire   +1 more source

Shiga Toxins

2003
D W, Acheson, A V, Kane, G T, Keusch
openaire   +2 more sources

Escherichia coli Shiga Toxins and Gut Microbiota Interactions

Toxins, 2021
Kyung-Soo Lee, Moo-Seung Lee
exaly  

Shiga toxins

2017
Christopher J. Silva   +3 more
openaire   +1 more source

Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics

Nature Reviews Microbiology, 2021
Shannon L Kordus, Dana Borden Lacy
exaly  

Shiga toxin-associated hemolytic uremic syndrome

The American Journal of the Medical Sciences, 2022
Tokio, Sasaki, Yuji, Suzuki
openaire   +2 more sources

Shiga Toxin

1996
Marie E. Fraser   +3 more
openaire   +1 more source

Shiga toxins

2015
Kirsten Sandvig   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy